See what CanVECTOR members are publishing to advance the field of venous thromboembolism
Publications since 2016 that are linked to venous thromboembolism and/or anticoagulant therapy

Publications for Marc Rodger

Updated daily

Back to Member List

#	PubMedId	Deleted	Publication
	42058833	0	Mai V, Martens ESL, Righini M, et al. Patterns of presentation of suspected and confirmed recurrent venous thromboembolism in patients with prior venous thromboembolism. Res Pract Thromb Haemost. 2026 Mar 25;10(3):103442. doi: 10.1016/j.rpth.2026.103442. eCollection 2026 Mar.
	41812192	0	Castellucci LA, Chen VM, Kovacs MJ, et al. Bleeding Risk with Apixaban vs. Rivaroxaban in Acute Venous Thromboembolism. N Engl J Med. 2026 Mar 12;394(11):1051-1060. doi: 10.1056/NEJMoa2510703.
	41560782	0	Collange F, Bistervels IM, Buchmuller A, et al. Assessment of clinical probability scores for pulmonary embolism diagnosis during pregnancy and postpartum in women with a history of venous thromboembolism: a Highlow ancillary study. Res Pract Thromb Haemost. 2025 Dec 5;10(1):103281. doi: 10.1016/j.rpth.2025.103281. eCollection 2026 Jan.
	41485833	0	Federspiel JJ, Rodger MA, Hoffman MR, et al. Postoperative venous thromboembolism following cesarean delivery: prevalence, pathophysiology, diagnosis, treatment, and prevention. Am J Obstet Gynecol. 2026 Jan;233(6S):S404-S424. doi: 10.1016/j.ajog.2025.07.055.
	40811855	0	Munsch G, Thibord F, Bezerra OC, et al. Molecular Determinants of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes. Blood. 2025 Aug 14:blood.2024027879. doi: 10.1182/blood.2024027879.
	40769433	0	Omar D, Kovacs MJ, Lazo-Langner A, et al. Racial Disparities in the Incidence and Risk Factors for Major Bleeding during Extended Anticoagulant Therapy for Venous Thromboembolism. J Thromb Haemost. 2025 Aug 4:S1538-7836(25)00489-1. doi: 10.1016/j.jtha.2025.07.026.
	40765707	0	Karsanji D, King JA, Godley J, et al. Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID-19 pandemic. Blood Vessel Thromb Hemost. 2024 Feb 24;1(1):100004. doi: 10.1016/j.bvth.2024.100004. eCollection 2024 Mar.
	40578691	0	Mai V, Martens ESL, Righini M, et al. Performance of clinical decision rules in patients presenting with suspected recurrent venous thromboembolism: a multicenter prospective cohort study. J Thromb Haemost. 2025 Jun 25:S1538-7836(25)00408-8. doi: 10.1016/j.jtha.2025.06.019.
	40086753	0	Andrew L, Garven A, Taylor TS, et al. Patient and healthcare providers' perspectives on participation in a postpartum pilot trial of venous thromboembolism prophylaxis: A qualitative study. J Thromb Haemost. 2025 Mar 12:S1538-7836(25)00141-2. doi: 10.1016/j.jtha.2025.02.039.
	39848545	0	Bezerra OCL, Rodger M, Munsch G, et al. Sex-specific DNA methylation marks associated with sex-biased risk of recurrence in unprovoked venous thromboembolism. J Thromb Haemost. 2025 Jan 21:S1538-7836(25)00010-8. doi: 10.1016/j.jtha.2025.01.004.
	39827892	0	Skeith L, Malinowski AK, El-Chaar D, et al. Low-dose aspirin versus placebo in postpartum venous thromboembolism: a multi-national, pilot, randomised, placebo-controlled trial. Lancet Haematol. 2025 Jan 15:S2352-3026(24)00338-7. doi: 10.1016/S2352-3026(24)00338-7.
	39677447	0	Munsch G, Thibord F, Bezerra OC, et al. Genomic Landscape of Thrombosis Recurrence Risk Across Venous Thromboembolism Subtypes. medRxiv [Preprint]. 2024 Dec 3:2024.12.02.24317788. doi: 10.1101/2024.12.02.24317788.
	37801772	0	Xu Y, Khan F, Kovacs MJ, et al. Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort study. Thromb Res. 2023 Sep 26;231:32-38. doi: 10.1016/j.thromres.2023.09.012.
	37364263	0	Khan F, Coyle D, Thavorn K, et al. Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Cost-Effectiveness Study. Ann Intern Med. 2023 Jun 27. doi: 10.7326/M22-3559.
	36809776	0	Pradier M, Rodger MA, Ghanima W, et al. Performance and head-to head comparison of three clinical models to predict occurrence of post-thrombotic syndrome. A validation study. Thromb Haemost. 2023 Feb 21. doi: 10.1055/a-2039-3388.
	36781052	0	Kahn SR, Matino D, Carrier M, et al. First-Person Call to Attend 2023 Congress. J Thromb Haemost. 2023 Feb 11:S1538-7836(23)00117-4. doi: 10.1016/j.jtha.2023.01.039.
	36740040	0	Robin P, Le Pennec R, Eddy M, et al. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: a systematic review and meta-analysis of individual participant data. J Thromb Haemost. 2023 Feb 3:S1538-7836(23)00084-3. doi: 10.1016/j.jtha.2023.01.030.
	36710196	0	Caiano L, Kovacs MJ, Lazo-Langner A, et al. The risk of major bleeding in patients with factor V Leiden or prothrombin G20210A gene mutation while on extended anticoagulant treatment for venous thromboembolism. J Thromb Haemost. 2022 Dec 30:S1538-7836(22)19071-9. doi: 10.1016/j.jtha.2022.12.021.
	36696186	0	Caiano LM, Drury T, Zahrai A, et al. Role of statins in the prevention of post-thrombotic syndrome after a deep vein thrombosis event: a systematic review and meta-analysis. J Thromb Haemost. 2022 Dec 22:S1538-7836(22)18246-2. doi: 10.1016/j.jtha.2022.12.008.
	36695396	0	Bistervels IM, Wiegers HMG, Ainle FN, et al. Onset of labor and use of analgesia in women using thromboprophylaxis with 2 doses of low-molecular-weight heparin: insights from the Highlow study. J Thromb Haemost. 2023 Jan;21(1):57-67. doi: 10.1016/j.jtha.2022.11.004. Epub 2022 Dec 22.
	36609323	0	Khan F, Thavorn K, Coyle D, et al. Protocol for a modelling study to assess the clinical and cost-effectiveness of indefinite anticoagulant therapy for first unprovoked venous thromboembolism. BMJ Open. 2023 Jan 6;13(1):e053927. doi: 10.1136/bmjopen-2021-053927.
	36354038	0	Bistervels IM, Buchmuller A, Wiegers HMG, et al. Intermediate-dose versus low-dose low-molecular-weight heparin in pregnant and post-partum women with a history of venous thromboembolism (Highlow study): an open-label, multicentre, randomised, controlled trial. Lancet. 2022 Oct 28. pii: S0140-6736(22)02128-6. doi: 10.1016/S0140-6736(22)02128-6.
	35877546	0	Abdulrehman J, Elbaz C, Aziz D, et al. Recurrence after stopping anticoagulants in women with combined oral contraceptive-associated venous thromboembolism: A systematic review and meta-analysis. Br J Haematol. 2022 Jul 25. doi: 10.1111/bjh.18331.
	35679460	0	Wells PS, Tritschler T, Khan F, et al. Predicting major bleeding during extended anticoagulation for unprovoked or weakly provoked venous thromboembolism. Blood Adv. 2022 Jun 9. pii: 485510. doi: 10.1182/bloodadvances.2022007027.
	35344784	0	Delluc A, Ghanima W, Kovacs MJ, et al. Prevention of post-thrombotic syndrome with rosuvastatin: A multicenter randomized controlled pilot trial (SAVER). Thromb Res. 2022 Mar 19;213:119-124. doi: 10.1016/j.thromres.2022.03.014.
	35157815	0	Khan F, Tritschler T, Le Gal G, et al. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism. Ann Intern Med. 2022 Feb;175(2):W14. doi: 10.7326/L21-0731.
	35021257	0	Ng S, Rodger MA, Ghanima W, et al. External validation of the patient reported Villalta scale for the diagnosis of post-thrombotic syndrome. Thromb Haemost. 2022 Jan 12. doi: 10.1055/a-1738-1313.
	34807722	0	Le Gal G, Kovacs MJ, Bertoletti L, et al. Risk for Recurrent Venous Thromboembolism in Patients With Subsegmental Pulmonary Embolism Managed Without Anticoagulation : A Multicenter Prospective Cohort Study. Ann Intern Med. 2021 Nov 23. doi: 10.7326/M21-2981.
	34795036	0	Caiano L, Sharkey R, Rodger MA, et al. Evaluation of the PADIS score stratifying risk for venous thromboembolism recurrence after a first unprovoked pulmonary embolism. Results from the REVERSE study. Eur Respir J. 2021 Nov 18. pii: 13993003.01801-2021. doi: 10.1183/13993003.01801-2021.
	34753191	0	Khan F, Rahman A, Tritschler T, et al. Long-term risk of major bleeding after discontinuing anticoagulation for unprovoked venous thromboembolism: a systematic review and meta-analysis. Thromb Haemost. 2021 Nov 9. doi: 10.1055/a-1690-8728.
	34564938	0	Delluc A, Ghanima W, Kovacs MJ, et al. Statins for venous event reduction in patients with venous thromboembolism: A multicenter randomized controlled pilot trial assessing feasibility. J Thromb Haemost. 2021 Sep 26. doi: 10.1111/jth.15537.
	34516270	0	Khan F, Tritschler T, Kimpton M, et al. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis. Ann Intern Med. 2021 Oct;174(10):1420-1429. doi: 10.7326/M21-1094. Epub 2021 Sep 14.
	34464871	0	Benmassaoud A, Rodger M. Challenging anticoagulation cases: Acute extensive portal vein thrombosis in a patient without cirrhosis - Evidence-based management of a rare clinical entity. Thromb Res. 2021 Oct;206:133-136. doi: 10.1016/j.thromres.2021.08.013. Epub 2021 Aug 18.
	34379859	0	Khan F, Tritschler T, Kimpton M, et al. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis. J Thromb Haemost. 2021 Nov;19(11):2801-2813. doi: 10.1111/jth.15491. Epub 2021 Aug 22.
	34327827	0	Roberge G, D'Astous J, Rodger M. Successful treatment of vaccine-induced prothrombotic immune thrombocytopenia (VIPIT): COMMENT from Roberge, et al. J Thromb Haemost. 2021 Aug;19(8):2091-2092. doi: 10.1111/jth.15369.
	34108229	0	Kovacs MJ, Wells PS, Anderson DR, et al. Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trial. BMJ. 2021 Jun 9;373:n1205. doi: 10.1136/bmj.n1205.
	33984268	0	Khan F, Tritschler T, Kahn SR, et al. Venous thromboembolism. Lancet. 2021 Jul 3;398(10294):64-77. doi: 10.1016/S0140-6736(20)32658-1. Epub 2021 May 10.
	33836493	0	Skeith L, Le Gal G, Rodger MA. Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism? Thromb Res. 2021 Jun;202:134-138. doi: 10.1016/j.thromres.2021.03.012. Epub 2021 Mar 25.
	33724705	0	Aziz D, Skeith L, Rodger MA, et al. Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort study. J Thromb Haemost. 2021 Jun;19(6):1526-1532. doi: 10.1111/jth.15303. Epub 2021 Apr 21.
	33472256	0	Skeith L, Rodger MA, Bates SM, et al. "Part of the Ritual": Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome. Thromb Haemost. 2021 Oct;121(10):1353-1360. doi: 10.1055/a-1366-9261. Epub 2021 Jan 20.
	32888372	0	Tritschler T, Mathieu ME, Skeith L, et al. Anticoagulant interventions in hospitalized patients with COVID-19: A scoping review of randomized controlled trials and call for international collaboration. J Thromb Haemost. 2020 Nov;18(11):2958-2967. doi: 10.1111/jth.15094. Epub 2020 Oct 1.
	32738644	0	Andrew L, Ni Ainle F, Blondon M, et al. Preventing postpartum venous thromboembolism: A call to action to reduce undue maternal morbidity and mortality. Thromb Res. 2020 Sep;193:190-197. doi: 10.1016/j.thromres.2020.07.007. Epub 2020 Jul 7.
	32654308	0	AlBader M, Le Gal G, Rodger MA, et al. Yield of ultrasonography in patients with or without post-thrombotic syndrome for diagnosis of suspected recurrent ipsilateral deep vein thrombosis. J Thromb Haemost. 2020 Oct;18(10):2654-2657. doi: 10.1111/jth.14996. Epub 2020 Aug 28.
	32539500	0	Kimpton M, Rodger MA. Web Exclusive. Annals for Hospitalists Inpatient Notes - Can I Withdraw Anticoagulants in This Patient With Prior Venous Thromboembolism? Ann Intern Med. 2020 Jun 16;172(12):HO2-HO3. doi: 10.7326/M20-1253.
	32416310	0	Delluc A, Lacut K, Rodger MA. Arterial and venous thrombosis: What's the link? A narrative review. Thromb Res. 2020 Jul;191:97-102. doi: 10.1016/j.thromres.2020.04.035. Epub 2020 Apr 27.
	31872492	0	Miranda S, Park J, Le Gal G, et al. Prevalence of confirmed antiphospholipid syndrome in 18-50 years unselected patients with first unprovoked venous thromboembolism. J Thromb Haemost. 2020 Apr;18(4):926-930. doi: 10.1111/jth.14720. Epub 2020 Feb 17.
	31812027	0	Cantor N, Carrier M, Rodger MA, et al. Predictors of long-term cancer diagnosis after an unprovoked thromboembolic event: A post-hoc analysis of the REVERSE cohort study. Thromb Res. 2020 Jan;185:132-134. doi: 10.1016/j.thromres.2019.11.021. Epub 2019 Nov 22.
	31661033	0	Khan F, Kimpton M, Tritschler T, et al. Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol. Syst Rev. 2019 Oct 28;8(1):245. doi: 10.1186/s13643-019-1175-5.
	31582557	0	Stephen MS, Castellucci L, Carrier M, et al. Safety of using direct oral anticoagulants in the diagnostic workup of outpatients with suspicion of acute venous thromboembolism. Haematologica. 2020 Jun;105(6):e307-e309. doi: 10.3324/haematol.2019.232884. Epub 2019 Oct 3.
	31402557	0	Tardy B, Chalayer E, Kamphuisen PW, et al. Definition of bleeding events in studies evaluating prophylactic antithrombotic therapy in pregnant women: A systematic review and a proposal from the ISTH SSC. J Thromb Haemost. 2019 Nov;17(11):1979-1988. doi: 10.1111/jth.14576. Epub 2019 Aug 12.
	31340984	0	Khan F, Rahman A, Carrier M, et al. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis. BMJ. 2019 Jul 24;366:l4363. doi: 10.1136/bmj.l4363.
	31279158	0	Rodger MA, Miranda S, Delluc A, et al. Management of suspected and confirmed recurrent venous thrombosis while on anticoagulant therapy. What next? Thromb Res. 2019 Aug;180:105-109. doi: 10.1016/j.thromres.2019.06.017. Epub 2019 Jun 26.
	30716777	0	Duffett L, Kearon C, Rodger M, et al. Treatment of Superficial Vein Thrombosis: A Systematic Review and Meta-Analysis. Thromb Haemost. 2019 Mar;119(3):479-489. doi: 10.1055/s-0039-1677793. Epub 2019 Feb 4.
	30709542	0	Versteeg HH, Rodger M. Bugs in the system. Thromb Res. 2019 Feb;174:166. doi: 10.1016/j.thromres.2019.01.004.
	30511879	0	Carrier M, Abou-Nassar K, Mallick R, et al. Apixaban to Prevent Venous Thromboembolism in Patients with Cancer. N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4.
	30504342	0	Rodger MA, Le Gal G. Who should get long-term anticoagulant therapy for venous thromboembolism and with what? Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):426-431. doi: 10.1182/asheducation-2018.1.426.
	30498046	0	Robin P, Eddy M, Sikora L, et al. Residual pulmonary vascular obstruction and recurrence after acute pulmonary embolism: protocol for a systematic review and meta-analysis of individual participant data. BMJ Open. 2018 Nov 28;8(11):e023939. doi: 10.1136/bmjopen-2018-023939.
	30487292	0	van der Wall SJ, van der Pol LM, Ende-Verhaar YM, et al. Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review. Eur Respir Rev. 2018 Nov 28;27(150). pii: 27/150/180094. doi: 10.1183/16000617.0094-2018. Print 2018 Dec 31.
	30482767	0	Bates SM, Rajasekhar A, Middeldorp S, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv. 2018 Nov 27;2(22):3317-3359. doi: 10.1182/bloodadvances.2018024802.
	30425073	0	Rodger MA, Le Gal G. Who should get long-term anticoagulant therapy for venous thromboembolism and with what? Blood Adv. 2018 Nov 13;2(21):3081-3087. doi: 10.1182/bloodadvances.2018020230.
	30349885	0	Ma KA, Kahn SR, Akaberi A, et al. Serial imaging after pulmonary embolism and correlation with functional limitation at 12 months: Results of the ELOPE Study. Res Pract Thromb Haemost. 2018 Jun 17;2(4):670-677. doi: 10.1002/rth2.12123. eCollection 2018 Oct.
	30170635	0	Versteeg HH, Rodger M. It's all in your genes. Thromb Res. 2018 Sep;169:157. doi: 10.1016/j.thromres.2018.08.009.
	30031290	0	Rodger MA, Le Gal G, Langlois NJ, et al. "HERDOO2" clinical decision rule to guide duration of anticoagulation in women with unprovoked venous thromboembolism. Can I use any d-Dimer? Thromb Res. 2018 Sep;169:82-86. doi: 10.1016/j.thromres.2018.07.020. Epub 2018 Jul 17.
	29770793	0	Huisman MV, Barco S, Cannegieter SC, et al. Pulmonary embolism. Nat Rev Dis Primers. 2018 May 17;4:18028. doi: 10.1038/nrdp.2018.28.
	29466159	0	Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty. N Engl J Med. 2018 Feb 22;378(8):699-707. doi: 10.1056/NEJMoa1712746.
	29440340	0	Khan F, Le Gal G, Rodger MA. The authors respond to "Thrombophilia testing in venous thromboembolism". CMAJ. 2018 Feb 12;190(6):E172. doi: 10.1503/cmaj.68991.
	29433730	0	Versteeg HH, Rodger M. HAPPY NEW CAREER!! Thromb Res. 2018 Feb;162:87. doi: 10.1016/j.thromres.2018.01.022.
	29407624	0	Rodger M, Langlois N, Middeldorp S, et al. Initial strides for invent-VTE: Towards global collaboration to accelerate clinical research in venous thromboembolism. Thromb Res. 2018 Mar;163:128-131. doi: 10.1016/j.thromres.2018.01.050. Epub 2018 Jan 31.
	29353682	0	van Es N, Louzada M, Carrier M, et al. Predicting the risk of recurrent venous thromboembolism in patients with cancer: A prospective cohort study. Thromb Res. 2018 Mar;163:41-46. doi: 10.1016/j.thromres.2018.01.009. Epub 2018 Jan 9.
	29289275	0	Versteeg HH, Rodger M. The misfits of blood coagulation. Thromb Res. 2018 Jan;161:119. doi: 10.1016/j.thromres.2017.12.010.
	29224973	0	Wan T, Rodger M, Zeng W, et al. Residual pulmonary embolism as a predictor for recurrence after a first unprovoked episode: Results from the REVERSE cohort study. Thromb Res. 2018 Feb;162:104-109. doi: 10.1016/j.thromres.2017.11.020. Epub 2017 Dec 8.
	28942356	0	Ikesaka RT, Kahn SR, Galanaud JP, et al. The importance of post thrombotic syndrome as an outcome after deep venous thrombosis: A survey of Canadian thrombosis clinicians. Thromb Res. 2017 Nov;159:13-15. doi: 10.1016/j.thromres.2017.09.015. Epub 2017 Sep 15.
	28939565	0	Khan F, Rahman A, Carrier M, et al. Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis. BMJ Open. 2017 Sep 21;7(9):16950. doi: 10.1136/bmjopen-2017-016950.
	28874432	0	Khan F, Le Gal G, Rodger MA. Stopping anticoagulation in a woman with unprovoked venous thromboembolism. CMAJ. 2017 Sep 5;189(35):E1112-E1114. doi: 10.1503/cmaj.170327.
	28686913	0	Wan T, Skeith L, Karovitch A, et al. Guidance for the diagnosis of pulmonary embolism during pregnancy: Consensus and controversies. Thromb Res. 2017 Sep;157:23-28. doi: 10.1016/j.thromres.2017.06.025. Epub 2017 Jun 23.
	28561245	0	Skeith L, Rodger MA. Pulmonary Complications of Pregnancy: Venous Thromboembolism. Semin Respir Crit Care Med. 2017 Apr;38(2):135-147. doi: 10.1055/s-0037-1602241. Epub 2017 May 22.
	28511036	0	Versteeg HH, Rodger M. Proliferation. Thromb Res. 2017 Jun;154:106. doi: 10.1016/j.thromres.2017.05.004. Epub 2017 May 13.
	28314711	0	Rodger MA, Le Gal G, Anderson DR, et al. Validating the HERDOO2 rule to guide treatment duration for women with unprovoked venous thrombosis: multinational prospective cohort management study. BMJ. 2017 Mar 17;356:j1065. doi: 10.1136/bmj.j1065.
	28137540	0	Versteeg HH, Rodger M. Of matters great and small. Thromb Res. 2017 Feb;150:101. doi: 10.1016/j.thromres.2017.01.005.
	28049641	0	Skeith L, Carrier M, Robinson SE, et al. Risk of venous thromboembolism in pregnant women with essential thrombocythemia: a systematic review and meta-analysis. Blood. 2017 Feb 23;129(8):934-939. doi: 10.1182/blood-2016-09-728006. Epub 2017 Jan 3.
	27955767	0	Versteeg HH, Rodger M. On societal and hemostatic changes. Thromb Res. 2016 Dec;148:135. doi: 10.1016/j.thromres.2016.11.019.
	27816104	0	Rodger M, Versteeg HH. Striking the right balance. Thromb Res. 2016 Nov;147:126. doi: 10.1016/j.thromres.2016.10.017.
	27729165	0	Versteeg HH, Rodger M. World Thrombosis Day. Thromb Res. 2016 Oct;146:105. doi: 10.1016/j.thromres.2016.09.027.
	27641645	0	Rodger M, Versteeg HH. We're number 3! Thromb Res. 2016 Sep;145:129. doi: 10.1016/j.thromres.2016.08.025.
	27503245	0	Rodger M, Versteeg HH. An inflammatory fascination for thrombosis. Thromb Res. 2016 Aug;144:224-5. doi: 10.1016/j.thromres.2016.07.009.
	27338843	0	Rodger M, Versteeg H. Tribute to Editor in Chief Per Morten Sandset. Thromb Res. 2016 Jul;143:149. doi: 10.1016/j.thromres.2016.06.004.
	27318246	0	Ma K, Wells P, Guzman C, et al. A multicenter prospective study of risk factors and treatment of unusual site thrombosis. Thromb Res. 2016 Aug;144:100-5. doi: 10.1016/j.thromres.2016.04.014. Epub 2016 Apr 26.
	27289488	0	Bleker SM, Buchmuller A, Chauleur C, et al. Low-molecular-weight heparin to prevent recurrent venous thromboembolism in pregnancy: Rationale and design of the Highlow study, a randomised trial of two doses. Thromb Res. 2016 Aug;144:62-8. doi: 10.1016/j.thromres.2016.06.001. Epub 2016 Jun 3.
	27159419	0	Khan F, Carrier M, Rodger M. Cancer Screening After Unprovoked Venous Thromboembolism: A Teachable Moment. JAMA Intern Med. 2016 Jun 1;176(6):739-40. doi: 10.1001/jamainternmed.2016.1783.
	27143030	0	Rodger M, Versteeg HH. Changing the guard. Thromb Res. 2016 May;141:196-7. doi: 10.1016/j.thromres.2016.04.009.
	27096813	0	Rodger MA, Phillips P, Kahn SR, et al. Low molecular weight heparin to prevent postpartum venous thromboembolism: A pilot study to assess the feasibility of a randomized, open-label trial. Thromb Res. 2016 Jun;142:17-20. doi: 10.1016/j.thromres.2016.04.004. Epub 2016 Apr 9.
	27086275	0	Rodger MA, Scarvelis D, Kahn SR, et al. Long-term risk of venous thrombosis after stopping anticoagulants for a first unprovoked event: A multi-national cohort. Thromb Res. 2016 Jul;143:152-8. doi: 10.1016/j.thromres.2016.03.028. Epub 2016 Mar 29.
	27031923	0	Gauthier K, Le Gal G, Shivakumar S, et al. Inter-observer reliability of the HERDOO2 clinical decision rule. Thromb Res. 2016 May;141:136-8. doi: 10.1016/j.thromres.2016.03.015. Epub 2016 Mar 15.
	26990353	0	Clark EG, Rodger MA, Ramsay TO, et al. Effectiveness of a computerized decision support system for anticoagulation management in hemodialysis patients: A before-after study. Hemodial Int. 2016 Oct;20(4):530-536. doi: 10.1111/hdi.12411. Epub 2016 Mar 17.
	26780741	0	Bates SM, Middeldorp S, Rodger M, et al. Guidance for the treatment and prevention of obstetric-associated venous thromboembolism. J Thromb Thrombolysis. 2016 Jan;41(1):92-128. doi: 10.1007/s11239-015-1309-0.
	26095467	0	Carrier M, Lazo-Langner A, Shivakumar S, et al. Screening for Occult Cancer in Unprovoked Venous Thromboembolism. N Engl J Med. 2015 Aug 20;373(8):697-704. doi: 10.1056/NEJMoa1506623. Epub 2015 Jun 22.
	26034913	0	Amin Q, Perry JJ, Stiell IG, et al. Ambulatory vital signs in the workup of pulmonary embolism using a standardized 3-minute walk test. CJEM. 2015 May;17(3):270-8. doi: 10.1017/cem.2014.45.
	25819750	0	Rodger M, Sheppard D, Gandara E, et al. Haematological problems in obstetrics. Best Pract Res Clin Obstet Gynaecol. 2015 Jul;29(5):671-84. doi: 10.1016/j.bpobgyn.2015.02.004. Epub 2015 Mar 4.
	25713501	0	Moretto P, Park J, Rodger M, et al. A survey of thrombosis experts evaluating practices and opinions regarding venous thromboprophylaxis in patients with active cancer hospitalized with an acute medical illness. Thromb J. 2015 Feb 14;13:10. doi: 10.1186/s12959-015-0040-6. eCollection 2015.
	25399526	0	Duffett L, Rodger M. LMWH to prevent placenta-mediated pregnancy complications: an update. Br J Haematol. 2015 Mar;168(5):619-38. doi: 10.1111/bjh.13209. Epub 2014 Nov 15.
	25373438	0	Rodger MA, Phillips P, Kahn SR, et al. Low-molecular-weight heparin to prevent postpartum venous thromboembolism. A pilot randomised placebo-controlled trial. Thromb Haemost. 2015 Jan;113(1):212-6. doi: 10.1160/TH14-06-0485. Epub 2014 Nov 6.